NCM
MED icon

Nantahala Capital Management’s Medifast MED Stock Holding History

Nantahala Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,000
Closed -$3.11M – 136
2023
Q1 		$3.11M Hold
30,000
– – 0.3% 65
2022
Q4 		$3.46M Buy
+30,000
New +$3.49M 0.31% 62
2020
Q3 		– Sell
-272,957
Closed -$37.9M – 126
2020
Q2 		$37.9M Hold
272,957
– – 2.45% 21
2020
Q1 		$17.1M Buy
272,957
+142,957
+110% +$13M 1.4% 31
2019
Q4 		$14.2M Buy
130,000
+8,593
+7% +$832K 0.94% 43
2019
Q3 		$12.6M Buy
+121,407
New +$13M 0.92% 46

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return